<DOC>
	<DOCNO>NCT02527200</DOCNO>
	<brief_summary>This trial conduct globally . The aim trial investigate effect liraglutide weight management paediatric subject Prader-Willi Syndrome .</brief_summary>
	<brief_title>Effect Liraglutide Weight Management Paediatric Subjects With Prader-Willi Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Prader-Willi Syndrome</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Informed consent obtain trialrelated activity . Trialrelated activity procedure carry part trial , include activity determine suitability trial Confirmed diagnosis PWS ( PraderWilli Syndrome ) ( genetic testing ) Male female , age time sign informed consent : Part A : equal 12 year less 18 year Tanner stage 25 pubertal development part A , Tanner stage 1 part B BMI ( body mass index ) correspond equal 30 kg/m^2 adult international cutoff points1 equal 95th percentile age sex ( diagnosis obesity ) Stable body weight previous 90 day screen ( 10 kg selfreported weight change ) Testing perform evaluate adrenal insufficiency document medical record Type 1 diabetes mellitus ( T1DM ) Type 2 diabetes mellitus ( T2DM ) Calcitonin equal 50 ng/L No change treatment plan growth hormone ( GH ) randomisation end openlabel period patient growth hormone stay , patient GH stay period . Adjustments dose growth hormone permit ) Family personal history Multiple Endocrine Neoplasia Type 2 ( MEN2 ) Medullary Thyroids Carcinoma ( MTC ) History pancreatitis ( acute chronic ) Treatment medication prescribe weight loss within 90 day screen ( e.g . orlistat , zonisamide , topiramate/phentermine , lorcaserin , phentermine , bupropion/naltrexone , liraglutide , metformin ) Untreated adrenal insufficiency Suggestive history , significant risk gastroparesis ( e.g . mark abdominal bloating post meal , history vomiting , severe constipation ) , judge Investigator</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>